New Zealand markets close in 1 hour 5 minutes

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9985+0.0385 (+4.01%)
At close: 04:00PM EDT
0.9986 +0.00 (+0.01%)
After hours: 07:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.82M
Enterprise value 7.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.07
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 3-13.51%
S&P500 52-week change 321.33%
52-week high 34.3700
52-week low 30.8600
50-day moving average 31.1358
200-day moving average 31.4709

Share statistics

Avg vol (3-month) 3100.65k
Avg vol (10-day) 3119.24k
Shares outstanding 514.4M
Implied shares outstanding 614.4M
Float 814.15M
% held by insiders 11.68%
% held by institutions 112.27%
Shares short (15 Apr 2024) 4255.37k
Short ratio (15 Apr 2024) 42.49
Short % of float (15 Apr 2024) 42.01%
Short % of shares outstanding (15 Apr 2024) 41.77%
Shares short (prior month 15 Mar 2024) 489.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Sept 2018
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 305 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-68.96%
Return on equity (ttm)-182.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -9.75M
Net income avi to common (ttm)-10.74M
Diluted EPS (ttm)-1.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.38M
Total cash per share (mrq)0.44
Total debt (mrq)231k
Total debt/equity (mrq)5.13%
Current ratio (mrq)2.09
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-8.53M
Levered free cash flow (ttm)-3.81M